ABOS
Price
$1.20
Change
+$0.13 (+12.15%)
Updated
Jun 6 closing price
Capitalization
64.51M
71 days until earnings call
CBUS
Price
$1.66
Change
+$0.11 (+7.10%)
Updated
Jun 6 closing price
Capitalization
50.64M
Interact to see
Advertisement

ABOS vs CBUS

Header iconABOS vs CBUS Comparison
Open Charts ABOS vs CBUSBanner chart's image
Acumen Pharmaceuticals
Price$1.20
Change+$0.13 (+12.15%)
Volume$383.45K
Capitalization64.51M
Cibus
Price$1.66
Change+$0.11 (+7.10%)
Volume$1.84M
Capitalization50.64M
ABOS vs CBUS Comparison Chart
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CBUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. CBUS commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a StrongBuy and CBUS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (ABOS: $1.02 vs. CBUS: $3.09)
Brand notoriety: ABOS and CBUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 158% vs. CBUS: 157%
Market capitalization -- ABOS: $64.51M vs. CBUS: $50.64M
ABOS [@Biotechnology] is valued at $64.51M. CBUS’s [@Biotechnology] market capitalization is $50.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileCBUS’s FA Score has 1 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • CBUS’s FA Score: 1 green, 4 red.
According to our system of comparison, CBUS is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 1 TA indicator(s) are bullish while CBUS’s TA Score has 4 bullish TA indicator(s).

  • ABOS’s TA Score: 1 bullish, 4 bearish.
  • CBUS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CBUS is a better buy in the short-term than ABOS.

Price Growth

ABOS (@Biotechnology) experienced а -1.92% price change this week, while CBUS (@Biotechnology) price change was +12.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

ABOS is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABOS($64.5M) has a higher market cap than CBUS($50.6M). CBUS YTD gains are higher at: 11.151 vs. ABOS (-40.698). ABOS has higher annual earnings (EBITDA): -77.89M vs. CBUS (-241.64M). ABOS has more cash in the bank: 200M vs. CBUS (14.4M). ABOS has less debt than CBUS: ABOS (28.5M) vs CBUS (36.3M). CBUS has higher revenues than ABOS: CBUS (4.26M) vs ABOS (0).
ABOSCBUSABOS / CBUS
Capitalization64.5M50.6M127%
EBITDA-77.89M-241.64M32%
Gain YTD-40.69811.151-365%
P/E RatioN/AN/A-
Revenue04.26M-
Total Cash200M14.4M1,389%
Total Debt28.5M36.3M79%
FUNDAMENTALS RATINGS
CBUS: Fundamental Ratings
CBUS
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABOSCBUS
RSI
ODDS (%)
N/A
Bearish Trend 12 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
90%
Momentum
ODDS (%)
Bearish Trend 12 days ago
86%
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
89%
Bullish Trend 12 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
87%
Bullish Trend 12 days ago
79%
Advances
ODDS (%)
Bullish Trend 24 days ago
77%
Bullish Trend 12 days ago
83%
Declines
ODDS (%)
Bearish Trend 18 days ago
88%
Bearish Trend 19 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 12 days ago
84%
Aroon
ODDS (%)
Bearish Trend 12 days ago
90%
Bullish Trend 12 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CBUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with ATOS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then ATOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
N/A
ATOS - ABOS
50%
Loosely correlated
-3.13%
CRBU - ABOS
49%
Loosely correlated
+2.75%
BEAM - ABOS
49%
Loosely correlated
-0.88%
FHTX - ABOS
49%
Loosely correlated
+6.17%
ABCL - ABOS
48%
Loosely correlated
+3.03%
More

CBUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CBUS has been loosely correlated with ABOS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CBUS jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CBUS
1D Price
Change %
CBUS100%
+8.42%
ABOS - CBUS
43%
Loosely correlated
N/A
CRBU - CBUS
37%
Loosely correlated
+2.75%
FHTX - CBUS
37%
Loosely correlated
+6.17%
CGEM - CBUS
36%
Loosely correlated
+0.26%
DNLI - CBUS
36%
Loosely correlated
-1.29%
More